Kolexia
Meyer Guy
Pneumologie
Hôpital Européen Georges Pompidou
Paris, France
321 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Embolie pulmonaire Embolie Thromboembolisme veineux Thromboembolie Hémorragie Thrombose Thrombose veineuse Maladie aigüe Tumeurs du poumon

Industries

Leo Pharma
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Plasma Tissue Factor Activity in lung cancer patients predicts venous thrombo-embolism and poor overall survival
Research and practice in thrombosis and haemostasis   01 mars 2024
Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data
65th ASH Annual Meeting Abstracts   02 novembre 2023
PEITHO-3: A Reduced Dose of Thrombolytic Treatment for Patients With Intermediate High-risk Acute Pulmonary Embolism: a Randomized Controled Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   18 octobre 2023
French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update.
Respiratory medicine and research   10 octobre 2023
Traitement de la maladie veineuse thromboembolique au cours du cancer Mise à jour Avril 2023: Treatment of cancer associated thrombosis. 2023 update of the french guidelines
Revue des maladies respiratoires actualites   01 octobre 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.
Thrombosis research   28 septembre 2023
Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued.
Cancers   31 juillet 2023
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients.
NEJM evidence   27 juin 2023
Reasons Influencing Long-Term Anticoagulant Treatment Beyond 6 Months for Cancer-Associated Thrombosis in USCAT, A 432-Patient Retrospective Non-Interventional Study.
Journal of cancer science and clinical therapeutics   16 mai 2023
Chatbot-based serious games: A useful tool for training medical students? A randomized controlled trial.
PloS one   13 mars 2023